Drugs against valsartan recalled because of a cancer alert



[ad_1]

Several cases of heart failure and hypoglycemic agents containing valsartan have been recalled for fear of causing cancer in users.

According to the South African Health Products Regulatory Authority (SAHPRA), an impurity was found in some cases. Drugs containing valsartan in South Africa

The following drugs containing valsartan are recalled:

– Dynaval Co 80 / 12.5 mg, tablet, 44 / 7.1.3 / 0018 [19659002] – Dynaval Co 160 / 12.5mg, tablet, 44 / 7.1.3 / 0019

– Tablet Dynaval Co 160 / 25mg, 44 / 7.1.3 / 0020

Recall was triggered due to detection N-nitrosodimethylamine (NDMA) in the active substance valsartan that a Chinese company provides to manufacturers producing the affected drugs.

N-nitrosodimethylamine is classified as possibly carcinogenic to humans, based on laboratory test results

"Carcinogen is a known substance which, when exposed to the tissue living, can lead er, "the regulator said in a statement Wednesday.

ALSO READ: Multi-million rand drug bust in the East

People who take medication with the substance in should consult a doctor

The Authority Regulatory Affairs said that drugs against valsartan treated conditions such as heart failure and high blood pressure.

"Patients could be injured if they suddenly stopped taking these medications without replacement medication."

SAHPRA "You may receive another medicine for valsartan (or other treatment) when you consult your doctor. doctor or pharmacist. Your blood pressure should be monitored closely during the change process.

Reminder letters have already been distributed to health professionals.

Do you have more information on history? Please send us an e-mail at [email protected] or call us at 083 625 4114.

For free information on the breakup, check out the Rekord websites:

Rekord East

North Rekord

Rekord Centurion

Rekord Moot

For more news and more interesting articles, like Rekord on Facebook, follow us on Twitter or Instagram

[ad_2]
Source link